Saint Louis, MO – Tekton Research is proud to announce its partnership with Dr. Ernest A. Graypel, a highly regarded psychiatrist and researcher, Board Certified in Psychiatry and Neurology. This effort supports Tekton’s expanding capabilities in central nervous system (CNS) research, particularly in Behavioral Health sciences. As the Medical Director of Community and Long-Term Care Psychiatry, Dr. Graypel brings a wealth of expertise in geriatric psychiatry, long-term care, and advanced psychiatric treatments, further strengthening Tekton Research’s commitment to driving innovation in the industry.
Dr. Graypel received his medical degree from Saratov State Medical University in the former Soviet Union. There, he was active as a physician and was involved in clinical research, which resulted in 16 publications, 2 of which being presented internationally. In 1992, he and his family relocated to the United States, where he founded a home healthcare business, and then became a licensed nursing home administrator and owner-operator of three assisted living facilities. For over a decade, Dr. Graypel successfully managed all his enterprises, was focusing on patient care, and was able to financially support his family.
Despite the fairly good success of his business endeavors, Dr. Graypel still felt that his life lacked an important aspect: direct clinical work as a physician. To satisfy his cravings for hands-on clinical work while still managing his businesses, he successfully passed all of the medical license examinations and completed psychiatry residency training. Additionally, during his board preparation, Dr. Graypel completed a Master of Healthcare Administration program and obtained an MHA Degree.
Upon completing his residency, Dr. Graypel assumed numerous significant leadership positions. He served as the Medical Director of Behavioral Health at Saint Anthony’s Hospital and for several years was the Statewide Psychiatric Director for the Missouri Department of Corrections. In addition to these leadership roles, he also served as an educator. He is a Clinical Associate Professor at A.T. Still University, and was a Clinical Instructor at St. Louis University. He authored the book Graypel’s Review of Dementias and Adult Cognitive Impairments for Non-Psychiatrists, which is published by the Lambert Academic Publishing internationally.
With a career dedicated to treating patients with mental illnesses and cognitive impairments, Dr. Graypel has worked extensively in private practice, personally treating patients in several hospitals, and overseeing psychiatric and psychological care in nursing home facilities and his outpatient clinic. Dr. Graypel integrates medication management, psychotherapy, and advanced treatments such as esketamine therapy, further expanding the range of advanced treatment options he offers.
His dedication to advancing mental health care has earned Dr. Graypel a lifetime membership in the Trademark Top Doctors of America.
“I am excited to leverage the resources of Tekton Research to contribute to bringing new medicines to the CNS market, as gaps still remain in treatments of mood, anxiety disorders, and dementia.” stated Dr. Graypel.
Dr. Graypel’s addition highlights Tekton Research’s dedication to broadening its CNS capabilities and supporting groundbreaking research in psychiatric and neurodegenerative disorders. His experience and patient-centered approach will play a key role in advancing clinical trials that address vital needs in mental health.
“We are thrilled to welcome Dr. Graypel to Tekton Research as we continue expanding our CNS and behavioral health presence,” said Corey Collins, President of Tekton Research. “His extended experience in the CNS indications we are targeting aligns perfectly with our plans to grow Tekton, while remaining committed to our mission of Making Life Better.”
